BDBM62088 5-chloranyl-4-(4-methoxyphenoxy)-2-(4-methylphenyl)pyridazin-3-one::5-chloro-4-(4-methoxyphenoxy)-2-(4-methylphenyl)-3(2H)-pyridazinone::5-chloro-4-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-pyridazinone::5-chloro-4-(4-methoxyphenoxy)-2-(4-methylphenyl)pyridazin-3-one::5-chloro-4-(4-methoxyphenoxy)-2-(p-tolyl)pyridazin-3-one::MLS000326740::SMR000179329::cid_1479652

SMILES COc1ccc(Oc2c(Cl)cnn(-c3ccc(C)cc3)c2=O)cc1

InChI Key InChIKey=MNCQCCQZOQVQKT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62088   

TargetNeuropeptides B/W receptor type 1(Human)
The Scripps Research Institute

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 62088BDBM62088(cid_1479652 | 5-chloro-4-(4-methoxyphenoxy)-2-(4-m...)
Affinity DataIC50: 2.20E+3nMAssay Description:Antagonist activity at human NPBWR1 expressed in HEK293T cells co-expressing Galphaqi3 assessed as calcium release after 15 mins by FLIPR assay assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed